$80M exit facility
Company: Core Scientific
The claim, verbatim
An $80 million exit delayed draw term loan ($40 million roll-up, $40 million new money) at 9.0% cash interest with a 3-year maturity provides liquidity on emergence.
Source (primary)
core-scientific 8-K exhibit (d661343dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-13)Live source ↗
Quote: “$55 million equity rights offering and $80 million exit facility (of which $40 million is new money) provide liquidity upon emergence”
How we checked this
Checked on November 16, 2026. The cited source supports every part of this claim.
The debt terms table lists the Exit Delayed Draw Term Loan at $80 million ($40 million roll-up, $40 million new money), 9.0% cash interest and 3-year maturity, and the summary says it provides liquidity upon emergence.
Confirmed in the source:
- The exit facility is an $80 million delayed draw term loan
- The facility comprises a $40 million roll-up and $40 million of new money
- The exit delayed draw term loan carries 9.0% cash interest
- The exit delayed draw term loan has a 3-year maturity
- The exit facility provides liquidity upon emergence
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/d661343dex992.htm) in full (29,830 characters, retrieved November 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d661343dex992.htm)
Quote: “$55 million equity rights offering and $80 million exit facility (of which $40 million is new money) provide liquidity upon emergence”